Record quarter, margin pressure persists amid inflation and mix shift
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Hit FY27 margin band (23% within 23–25%), beat revenue/PAT growth, executed on new products. Margin at lower end, recovery timeline vague.
Optimistic
next 1–2 quarters
Optimistic
multi-year
Sona delivered a record quarter with 35% YoY revenue growth and impressive new product/order wins, validating its diversification into EV and EPIC mobility. However, EBITDA margins remain compressed at 23% (vs 25.3% prior year) due to unfavorable product mix and inflation headwinds, delaying the recovery narrative. Management maintains 23–25% FY27 guidance but is candid that cost pass-through lags. Near-term catalyst: strong order book (₹251 Bn) and EPIC ramp; key risk: margin recovery timing and JV execution.
₹1546.4 Cr
Revenue · +35.2% YoY₹223 Cr
Reported PAT · +30.8% YoYCompressing
Margins · vs guidance: CorroboratedDid the claims hold up?
Perfect quarter, highest ever revenue EBITDA PAT
METRevenue ₹1546 Cr (+35% YoY), EBITDA ₹356 Cr (+23%), PAT ₹223 Cr (+30.8%)
Margin recovery expected Q2 onwards as cost pass-throughs catch up
OVERSTATEDEBITDA margin 23% vs 25.3% Q2 FY26; recovery not yet visible, attributed to mix and inflation
EV business grew almost 50% QoQ, suspension motors fastest growing at 7% of revenue
METBEV revenue 51% of automotive; H1 BEV ₹1042 Cr +129% YoY; suspension motor growth strong but exact rate not disclosed
3rd highest order wins (₹36B), 2nd highest order book (₹251B)
METConfirmed ₹36B wins, ₹251B book
Commercialized 3 new products in Q2, highest ever
METHelical LSD, air springs, rear radar sensor delivered in Q2
Earnings quality
What changed since the last call
Margin recovery delayed
DowngradeQ1 FY27 call: 'Q2 onwards recovery expected.' Q2 reality: 23% (vs 25.3%), no recovery; inflation and mix cited as culprits, not resolved.
EV penetration accelerated
UpgradeBEV now 51% of automotive revenue (was 30% H1 FY26), +129% YoY; suspension motors and controllers winning at scale across geographies.
EPIC programs at 75 vs prior ambiguity
UpgradeManagement quantified 75 EPIC programs across 37 customers; 44 in production, 31 pending—concrete pipeline visibility.
No FY27 guidance cut despite headwinds
NeutralFY27 EBITDA band 23–25% reaffirmed; not cut despite inflation, freight, and mix pressure. Maintained at lower end.
The Q&A
Analysts pressed hard on margin path (Basudeb Banerjee), robotics ROI timeline (Pramod Kumar), and Denso JV visibility (Arvind Sharma). Management held firm on 23–25% range, candid on margin lag but defensive on recovery timeline. Q&A tone: confident but hedged—Vivek acknowledged uncertainties (S-curve for new products, robotics inflection timing) without committing dates.
Suspension motor orders pipeline — Arvind Sharma, Nomura
PartialVivek acknowledged S-curve trajectory and consumer adoption risk; orders now span variants, future looks bright. Denso JV timing confidential due to legal/timeline.
Legacy (DA/DG) business growth horizon — Chandramauli Muthia
DodgedVivek: India's history of high world market share is rare; Sona has 9% in differential—no Indian company has high share in most products. Confident in continued growth.
Traction motor wallet share expansion mechanics — Gunjan Prithyani, Citi
AnsweredSat Mohan: Both wallet share and market growth driving increase; 3-wheeler programs launching, share still small but with large TAM.
EBITDA margin guidance evolution — Basudeb Banerjee
AnsweredVivek: 23–25% is fair, contingent on oil not spiking beyond ₹150/barrel. Inflation exceptional, product mix drag transparent; Rohit outlined path where margin stacks up in next 5 years.
Robotics humanoid deployment and ROI timeline — Pramod Kumar, Goldman Sachs
DodgedVivek: Does not know inflection point; acknowledged S-curve trajectory for new tech. Cost side moving fast, simulation lagging. Evaluating like any capex—business case + payback period driven.
Guidance
No explicit FY27 revenue target; 10x over 10 years aspiration (CAGR ~26%)
LowSona 2.0 vision; dependent on EV penetration, EPIC ramp, robotics inflection—all uncertain timing.
FY27 EBITDA margin 23–25% reaffirmed (from Q1 call)
HighMaintained band, contingent on oil <₹150/barrel, material prices normalizing. Q2 at 23% (lower end); recovery narrative delayed.
Robotics capex: ₹62 Cr committed for Novelics AI/robotics; EPIC capex ongoing
MediumCapex for capacity & new product tooling; actual robotics ROI and deployment pace uncertain; ₹250B order book growth supports capex case.
Risks the call surfaced
Margin compression
HighEBITDA margin 23% (vs 25.3% prior year); driven by shift to traction motors and EV components (lower-margin) and inflation lag in cost pass-through. West Asia uncertainty adds freight volatility.
Supply chain stress
HighTraction motor demand surged almost 50% QoQ; while management says capacity exists, scaling production at this pace creates supply chain risk, especially for rare earth magnets and copper.
Customer concentration
MediumEastern markets now contribute 2/3 of revenue (up from 1/3 one year ago); geographic concentration and dependency on a few large OEMs. Diversification into new geographies ongoing but slower than concentration growth.
JV execution
MediumDenso JV1 (high-voltage systems) carve-out targeted for Dec 2026 (or Jan 2027 if holidays slip); JV2 formation timeline 1H CY27. Delays would push revenue from DENSO JVs into FY28, impacting growth targets.
Robotics inflection timing
MediumRobotics and physical AI aspiration ambitious; deployment timeline opaque. Pramod Kumar asked for inflection timeline; Vivek candidly said he doesn't know, acknowledging S-curve. ₹62 Cr capex committed but ROI and scale-up pace uncertain.
Management
Score 7/10. Transparent on challenges (margin pressure, inflation, mix dilution). Candid on uncertainties (robotics timeline, JV legal dependencies). Some evasion on Denso JV details and robotics inflection, citing confidentiality and complexity. Q&A handling mostly direct, with Vivek holding firm on guidance but hedging on near-term. Strong: Hit margin band (23% within 23–25%), beat revenue/PAT growth, delivered 3 new products, ₹36B order wins, ₹251B book secured. Track record of execution on diversification (EV now 51%) and product commercialization (highest rate). Margin lag vs. recovery narrative is the credibility dent.
1 · H2 FY27
EPIC programs ramp production (44/75 in production, 31 pending start)
2 · Dec 2026
JV1 carve-out (high-voltage systems SOP) closure targeted; JV2 formation in 1H CY27
3 · FY27 end
Robotics capability deployment; timeline for inflection opaque, aspiration only
Near-term catalyst: strong order book (₹251 Bn) and EPIC ramp; key risk: margin recovery timing and JV execution.
Informational and educational content only. Not investment advice.